STONY BROOK, NY / ACCESSWIRE / August 7, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release financial results for the three months ended June 30, 2023 after the market close on Thursday, August 10, 2023. The Company will host a conference call for the investment community to discuss the results and answer questions at 4:30 p.m. ET.
Date & Time: Thursday, August 10 @ 4:30 p.m. ET
Dial In:
A replay of the conference call will be available for 7 days following the conclusion of the call:
An accompanying slide presentation will be embedded in the webcast (live and replay) and can also be accessed in the ‘Company Events‘ section under the ‘News & Events’ tab of the Applied DNA website at https://investors.adnas.com/. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.
About Applied DNA Sciences
Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid (“DNA”). Using the polymerase chain reaction (“PCR”) to enable both the production and detection of DNA, we operate in three primary business markets: (i) the manufacture of DNA for use in nucleic acid-based therapeutics; (ii) the detection of DNA in molecular diagnostics testing services; and (iii) the manufacture and detection of DNA for industrial supply chain security services.
Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.
The Company’s common stock is listed on NASDAQ under the ticker symbol ‘APDN,’ and its publicly traded warrants are listed on OTC under the ticker symbol ‘APPDW.’
For additional information:
Investor Relations: Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com
Web: www.adnas.com
Twitter: @APDN
SOURCE: Applied DNA Sciences
View source version on accesswire.com:
https://www.accesswire.com/772642/Applied-DNA-to-Report-Third-Quarter-Fiscal-2023-Financial-Results-and-Host-Investor-Conference-Call-and-Webcast-on-Thursday-August-10-2023
Strategic collaboration brings advanced AI and CBCT imaging to more than 1,000 dental practices, enhancing…
Plan Confirmation and Sale Approval Court Date Expected in Early September GAINESVILLE, Fla., July 24,…
NEW YORK, LONDON, and ZURICH, July 24, 2025 /PRNewswire/ -- MedComms Experts ("MCE"), a global…
TORONTO, July 24, 2025 /CNW/ - Tali AI, the leading Canadian healthtech company focused on reducing…
ARLINGTON, Va., July 24, 2025 /PRNewswire/ -- The global fight against diabetes is accelerating—and diagnostic innovation…
PITTSBURGH, July 24, 2025 /PRNewswire/ -- "I thought there should be a way to keep…